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Thermogenic adipocytes promote HDL turnover
and reverse cholesterol transport
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Brown and beige adipocytes combust nutrients for thermogenesis and through their meta-
bolic activity decrease pro-atherogenic remnant lipoproteins in hyperlipidemic mice. However,
whether the activation of thermogenic adipocytes affects the metabolism and anti-athero-
genic properties of high-density lipoproteins (HDL) is unknown. Here, we report a reduction
in atherosclerosis in response to pharmacological stimulation of thermogenesis linked to
increased HDL levels in APOE*3-Leiden.CETP mice. Both cold-induced and pharmacological
thermogenic activation enhances HDL remodelling, which is associated with specific lipi-
domic changes in mouse and human HDL. Furthermore, thermogenic stimulation promotes
HDL-cholesterol clearance and increases macrophage-to-faeces reverse cholesterol transport
in mice. Mechanistically, we show that intravascular lipolysis by adipocyte lipoprotein lipase
and hepatic uptake of HDL by scavenger receptor B-I are the driving forces of HDL-choles-
terol disposal in liver. Our findings corroborate the notion that high metabolic activity of
thermogenic adipocytes confers atheroprotective properties via increased systemic
cholesterol flux through the HDL compartment.
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B
rown adipose tissue (BAT) is the primary organ for heat
production in small mammals in response to cold; BAT is
also present and active in humans1–7. While cold is the
natural stimulus8, thermogenic adipocytes can also be activated
by treatment with selective b3-adrenergic receptor agonists
such as CL316,243 (CL) in both mice and humans9,10. It is well
accepted that thermogenic adipocytes contribute to energy
expenditure in rodents and humans11–16, although the relative
contribution is larger in rodents. Nevertheless, the high metabolic
activity of BAT17–19 and adipose tissue browning, referring to the
formation of so-called beige adipocytes in white adipose tissue
(WAT)17,20,21, suggest that the activation of brown and beige
adipocytes may be successfully targeted to combat metabolic
diseases in humans. Apart from glucose, fatty acids are the main
fuel for the metabolic activity of BAT. We have shown that BAT
activity controls plasma levels of triglyceride (TG)-rich
lipoproteins (TRLs), both by selective uptake of TRL-derived
fatty acids that are liberated from TG by lipoprotein lipase (LPL)
as well as uptake of whole TRLs22,23.
Previously, we demonstrated that the activation of thermogenic
adipocytes reduces cholesterol levels and protects from athero-
sclerosis in transgenic mice expressing both a loss-of-function
variant of human apolipoprotein E (APOE*3-Leiden; E3L) and
the human cholesteryl ester transfer protein (E3L.CETP mice)9.
This mouse model, unlike apolipoprotein E-deficient mice or low-
density lipoprotein receptor-deficient mice24, responds well to the
lipid-lowering effects of thermogenic activation either with cold
or CL9. However, while the role of pro-atherogenic cholesterol-
rich TRL remnants in this context is well-understood9, whether
thermogenic adipocytes modulate the metabolism of HDL is
unclear. This is of importance, as HDL particles are key
components in the process of removing excess cholesterol from
cells in peripheral organs and possibly from macrophages in
atherosclerotic lesions25,26. HDL represents a special class of lipo-
proteins with a variety of biological activities27,28. The most broadly
studied function of HDL is facilitating cholesterol efflux from
cells and driving macrophage-to-faeces reverse cholesterol transport
(RCT)25,28. In this process, apolipoprotein AI-containing nascent
HDL act as acceptors for cellular cholesterol from macrophages
and other cells from peripheral organs29–33. Mature HDL particles
deliver their cargo to the liver, where cholesterol is selectively taken
up by hepatocytes via scavenger receptor B-I (SR-BI) and is processed
towards faecal excretion34,35. The role of plasma HDL-cholesterol
levels and their function in RCT with regard to atherosclerosis is
controversial36. However, recent studies indicate that the cholesterol
efflux capacity of HDL rather than total HDL-cholesterol level is
associated with cardiovascular outcomes37,38. The increased
cardiovascular risk in patients carrying loss-of-function SR-BI
mutations with high plasma HDL-cholesterol underline the
relevance of SR-BI-mediated cholesterol flux as an anti-atherogenic
mechanism39. However, the physiologic mechanisms that increase
HDL-mediated cholesterol flux remain unclear, which is of
importance for developing targeted HDL therapeutics.
Several lines of evidence indicate a role of thermogenic adipocytes
in the metabolism of HDL in humans. Dyslipidemia in patients with
obesity and type 2 diabetes, which have lower thermogenic
adipocyte activity than healthy subjects1,40, is characterized by
high plasma TG and low plasma HDL-cholesterol concentrations41.
Interestingly, repeated cryostimulation in humans has been
described to lower plasma TG while increasing plasma HDL-
cholesterol levels42. Likewise, the expression of uncoupling protein-1
(UCP1) in human epicardial fat is associated with lower plasma
TG and higher plasma HDL-cholesterol levels43. Notably, single-
nucleotide polymorphisms in the gene coding for LPL, the master
regulator of plasma TG, are linked to increased plasma TG and
reduced plasma HDL-cholesterol levels in humans44–46. Altogether,
based on these findings we hypothesized that the metabolic activity
of thermogenic adipocytes is linked to HDL metabolism.
Here we show that thermogenic activation accelerates HDL
turnover as well as RCT and leads to characteristic changes of the
HDL lipidome in humans and in mice. Although these lipid
changes are not associated with altered cholesterol efflux capacity
of isolated HDL ex vivo, activation of thermogenic adipocytes
accelerates plasma cholesterol flux and faecal excretion. Mechan-
istically, we demonstrate that LPL activation in adipocytes
promotes HDL turnover and hepatic clearance of cholesterol in
an SR-BI-dependent manner.
Results
CL-induced atheroprotection is linked to increased HDL.
Recently, we described that activation of thermogenic adipocytes
reduces total cholesterol levels and atherosclerosis by accelerating
lipoprotein remnant formation and clearance in female
E3L.CETP mice9. Interestingly, in addition to lowering of plasma
pro-atherogenic non-HDL-cholesterol levels9 we found in the
current study that chronic CL treatment increased HDL-
cholesterol in E3L.CETP mice fed a cholesterol-containing
Western-type diet (Fig. 1a). Multiple regression analysis showed
that, in addition to plasma non-HDL-cholesterol9, plasma HDL-
cholesterol was an independent predictor of atherosclerosis
development (Fig. 1b). These findings raise the possibility that
thermogenic adipocytes modulate HDL composition and/or
HDL-mediated cholesterol transport.
Thermogenic adipocytes modulate HDL-cholesterol in mice.
To investigate the effects of thermogenic adipocyte activation on
HDL metabolism in mice, we employed a treatment with either
cold or CL for 7 days. Both treatments led to BAT activation as
well as browning in WAT depots (Supplementary Figs 1 and 2).
To study the impact of thermogenic activation on the amount as
well as the composition of HDL in the context of different plasma
lipid concentrations, we used normolipidemic C57BL/6J wild-
type mice, hypertriglyceridemic Apoa5 / mice47 as well as
hypercholesterolemic E3L.CETP mice. Consistent with previous
data22, we observed a reduction in total plasma TG, especially in
hypertriglyceridemic Apoa5 / mice (Fig. 2a) whereas total
plasma cholesterol levels were mostly unaltered (Fig. 2b). In a fast
performance liquid chromatography (FPLC) analysis we found
that the lipoprotein cholesterol profiles (Fig. 2c,f) and HDL-
associated apolipoproteins AI, AV and CIII (Supplementary
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Figure 1 | Atheroprotective effects of thermogenic adipocytes are linked
to plasma HDL-cholesterol. (a) Fasting plasma HDL-cholesterol were
measured in Western-type diet-fed female E3L.CETP mice at the indicated
time points during treatment with CL316,243 (CL) or vehicle (control;
*Po0.05 determined by Student’s t-test, nZ13). (b) Correlation of HDL-
cholesterol levels in E3L.CETP mice with atherosclerotic plaque size after
CL treatment. Values in a are means±s.e.m. (nZ13 per group). *Po0.05
(a,b: univariate regression analysis).
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hypertriglyceridemic Apoa5 / mice both cold and CL
treatment induced a shift of cholesterol from the TRL fraction
to HDL, increasing the amount of HDL-cholesterol (Fig. 2d,g),
whereas in dyslipidemic E3L.CETP mice little change in the
cholesterol profile took place (Fig. 2e,h). Thus, a shift of
cholesterol from TRL to the HDL fraction was only observed in
Apoa5 / mice, which may be explained by a more pronounced
reduction of TRL-associated TG compared to the other mouse
models (Supplementary Fig. 4).
Thermogenic adipocytes remodel HDL lipids in mice. Next to
absolute lipoprotein levels, the lipid composition of lipoproteins
might be altered after the activation of thermogenic adipocytes.
To address this hypothesis, we performed a lipidomic analysis of
TRL and HDL particles isolated by FPLC using high-resolution,
full scan mass spectrometry with collision-induced dissociation
fragmentation. We first studied hyperlipidemic Apoa5 / as
they showed the most pronounced shift in lipoprotein pattern in
response to thermogenic activation. The lipidomic patterns of
HDL exhibited changes after cold exposure and CL treatment
(Fig. 3). Thermogenic activation led to remodelling of lipid pat-
terns including phosphatidylcholine (PC; Fig. 3a), lyso-PC
(Fig. 3c) as well as cholesteryl ester (CE; Fig. 3e) species. Notably,
the relative concentrations of Lyso-PC18:0 and the corresponding
PC species PC36:2 were increased, whereas HDL-associated Lyso-
PC18:1 and Lyso-PC16:0 as well as the corresponding PC species
PC36:3 and PC34:1 were decreased, especially after cold treat-
ment (Fig. 3a,c). In TRL, cold-dependent changes in surface PC
patterns were less pronounced but consistent with those in the
HDL fraction (Supplementary Fig. 5a). Subsequently, E3L.CETP
mice were investigated to address the potential role of the lipid
transfer activity mediated by CETP, which is present in humans
but not in mice. In E3L.CETP mice, thermogenic activation
caused changes in TRL and HDL-associated surface lipids
(Fig. 3b,d; Supplementary Fig. 5b), which were very similar to
those observed in Apoa5 / mice. Notably, cold-induced
changes in CE species were comparable between HDL and TRL in
E3L.CETP but not in Apoa5 / mice (Fig. 3e,f; Supplementary
Fig. 5c,d), indicating exchange of CE species between HDL and
TRL mediated by the CETP transgene. Taken together, these data
provide evidence for accelerated exchange of PC, Lyso-PC and
presumably other (minor) surface lipids between TRL and HDL
after thermogenic activation. These findings show that  irre-
spective of HDL-cholesterol concentrations  the HDL lipid
composition is remodelled by cold adaptation and to a similar
albeit smaller degree by pharmacologic activation with CL.
Cold exposure is linked to HDL remodelling in humans. As our
results were obtained in preclinical mouse models of hyperlipi-
demia, we explored how these findings translate into the human
situation, in which the activity of thermogenic adipocytes, as
determined by 18F-fluorodeoxyglucose positron emission
tomography–computed tomography (18F-FDG-PET-CT), is
inversely correlated to BMI and ageing2,4 but increased by cold
exposure1,3. To address this question, we analysed plasma
samples from lean or obese humans that underwent cold
exposure for 2 days at 16 C as previously described48. Cold
exposure had no significant impact on the lipoprotein profiles of
neither lean nor obese probands (Fig. 4a,b and Supplementary
Fig. 6a,b). However, when we analysed the lipidomic patterns of
isolated lipoprotein fractions, we found that, similar to our
observation in mice, HDL-associated PC34:1 and Lyso-PC18:1
were significantly reduced in lean humans by cold exposure
(Fig. 4c,d). In addition, Lyso-PC16:0 was significantly increased
while no significant changes in CE were observed (Fig. 4e). In
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Figure 2 | Thermogenic adipocytes modulate TRL and HDL levels in normo- and hyperlipidemic mice. Mice were either mock-treated (Mock), exposed
to 4 C (Cold) or treated with CL316,243 (CL) for 7 days. (a) Total plasma TG and (b) cholesterol as well as (c–h) corresponding cholesterol FPLC profiles
from plasma of (c,f) C57BL/6J, (d,g) Apoa5 / and (e,h) E3L.CETP mice. For FPLC analysis, individual plasma samples were analysed and cholesterol
levels were determined n each fraction (n¼4–5 per group). Values are means±s.e.m. Significance was calculated using unpaired two-tailed Student’s t-
test. *Po0.05, versus mock.
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observed (Fig. 4c–e), which is in line with the concept that obesity
is a state of low thermogenic adipocyte activity. In summary, in
both mice and lean humans HDL surface lipids are remodelled in
a similar way after cold exposure irrespectively of total plasma
HDL-cholesterol concentrations.
Thermogenic adipocytes promote RCT in mice. The observed
changes in HDL lipid composition might be indicative of altered
HDL functions such as cellular cholesterol efflux. To address this
hypothesis, we analysed whether HDL isolated from mice after
cold adaptation or CL treatment increased cholesterol efflux from
primary mouse peritoneal macrophages ex vivo. Both serum as
well as HDL isolated from control mice promoted cholesterol
efflux from macrophages. However, the cholesterol efflux capacity
of serum and HDL were not different when HDL were isolated
from mice that were cold-adapted or CL-treated (Fig. 5a,b). These
data suggest that the lipidomic changes in HDL do not directly
alter the capacity of isolated HDL particles to induce cholesterol
efflux. Next, we compared the plasma clearance and hepatic
uptake of HDL isolated from mock- and CL-treated mice that
were radiolabelled ex vivo with 3H-cholesterylether (a non-
hydrolysable marker of the lipid core) and subsequently re-
injected into wild-type mice. Both clearance from plasma as well
as hepatic uptake of these HDL particles were identical (Fig. 5c,d),
indicating that the lipidomic changes in HDL neither directly
alter cholesterol efflux nor directly alter the transport capacity of
isolated HDL particles. However, this does not rule out that
thermogenic adipocytes mediate an enhanced flux of peripherally
acquired cholesterol via the HDL compartment towards the liver.
To investigate this hypothesis in vivo, we performed an RCT
assay developed by the Rader laboratory49. Briefly, we injected
macrophages loaded ex vivo with LDL and 3H-cholesterol into
mice, in which thermogenic adipocytes were activated by cold or
CL. In comparison to wild-type mice housed under
thermoneutral conditions, cold-adapted mice showed markedly
increased 3H-cholesterol excretion into faeces, while the
concentration of 3H-cholesterol in plasma and liver was
decreased (Fig. 5e–g). CL treatment led to comparable
outcomes including significantly increased faecal excretion of
radiolabelled cholesterol. Similarly, we observed increased levels
of faecal 3H-cholesterol after cold or CL treatment in
hyperlipidemic E3L.CETP mice (Fig. 5h–j). Taken together,
these data indicate that the activation of thermogenic adipocytes
increases cholesterol flux from the periphery to faeces, possibly by
accelerated transport via HDL.
Thermogenic adipocytes accelerate HDL-cholesterol flux in mice.
To unravel whether the observed increase in RCT is dependent
on changes in HDL-mediated plasma cholesterol transport to the
liver and subsequently to bile, we investigated HDL turnover in
cold-adapted and control wild-type mice housed at thermo-
neutrality. For this purpose, we labelled HDL isolated from wild-
type mice with 3H-cholesterylether (a marker of cholesterol
uptake) and 125I-apolipoprotein (a marker of particle uptake)50
and injected these radiolabelled particles into controls and mice,
in which thermogenic adipocytes were activated. The double-
radiolabelling allows the analysis of selective cholesterol plasma
clearance50. In this set-up, an accelerated selective cholesterol
clearance from plasma is indicated by a lower ratio of 3H/125I
while impaired selective plasma clearance results in a higher 3H/
125I ratios. Cold adaptation increased both total and selective
cholesterol clearance from plasma without changing the uptake of
3H-cholesterylether into the liver of fasted mice (Fig. 6a–c). Next,
we performed HDL turnover experiments with re-fed mice, as
under this condition LPL activity was increased in adipose tissues
(Supplementary Fig. 7). Notably, in this postprandial state with
increased plasma lipolysis, both total and selective cholesterol
clearance from plasma as well as liver uptake of HDL-derived
cholesterylether were increased, accompanied by elevated 3H-
cholesterylether concentration in the gallbladder (Fig. 6d–f).
Interestingly, disposal of 3H-cholesterylether (Fig. 6c,f) and to a
lesser degree 125I-HDL (Supplementary Fig. 8a,b) was also
increased in BAT and WAT after cold adaptation, suggesting
higher HDL uptake into adipose tissues. The stimulated
intravascular lipolytic environment caused by the induction of
LPL in thermogenic adipocytes (Supplementary Fig. 7) is likely
responsible for the increased HDL turnover and selective
cholesterol uptake into liver.
LPL-mediated lipolysis drives HDL remodelling and turnover inmice.
To prove this concept, we analysed the turnover and liver uptake
of HDL in cold-exposed mice with adipocyte-specific deletion of
LPL (aLKO)51. This model shows defective intravascular adipose
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Figure 3 | Thermogenic activation causes characteristic HDL lipidome
remodelling. Lipidomic analysis of HDL from (a,c,e) Apoa5 / and (b,d,f)
E3L.CETP mice after 7 days of CL or cold treatment. Changes in (a,b) PC,
(c,d) Lyso-PC, (e,f) CE species relative to mock-treated mice, determined
by high-resolution mass spectrometry, are represented as per cent weight
changes relative to the whole-lipid class. For example, a 5% change in a PC
species translates to, for example, 20% abundance of this lipid to 25% of
total PC. Calculated values are mean±s.e.m. (n¼4-5 per group). Post hoc
correction for multiple testing was performed using the Benjamini–
Hochberg method for the number of lipids shown. *Po0.05, **Po0.01,
***Po0.001, versus mock (Student’s t-test).
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intact51. Deficiency of adipocyte LPL reduced total and selective
plasma cholesterol clearance under conditions of cold adaptation
(Fig. 6g,h). Accordingly, we observed reduced uptake of HDL-
cholesterol (Fig. 6i) but not of 125I-HDL (Supplementary Fig. 8c)
into the liver. In line with a prominent role for adipose tissue LPL,
thermogenic activation caused lowering of TG levels in wild-type
mice but not in aLKO mice (Supplementary Fig. 9a,c,d). Neither
total cholesterol nor HDL-cholesterol levels were modulated in
this setting (Supplementary Fig. 9b,e,f). However, the mass
spectrometry with collision-induced dissociation fragmentation
lipidomic analysis confirmed that HDL-TRL remodelling
occurred in wild-type controls but was attenuated in aLKO
mice (Supplementary Figs 10 and 11). Taken together, these data
indicate that LPL-mediated lipolysis by thermogenic adipocytes is
a critical driver of HDL remodelling and turnover.
Cold-inducedHDL-cholesterol clearance is mediated by SR-BI inmice.
SR-BI (encoded by Scarb1) is the major HDL receptor mediating
selective cholesterol uptake into liver34,35. Hepatic levels of SR-BI
protein were unchanged in cold-adapted wild-type mice in
comparison to controls housed at thermoneutrality
(Supplementary Fig. 12), but may still be important for hepatic
cholesterol clearance under conditions of activated thermogenic
adipocytes. In comparison to wild-type controls, cold-adapted
Scarb1 / mice showed impaired total and selective cholesterol
clearance from plasma as well as decreased uptake of 3H-
cholesterylether into liver and gallbladder (Fig. 6j–l), while the
uptake of 125I-HDL was unaltered (Supplementary Fig. 8d). In
conclusion, hepatic SR-BI is involved in the accelerated HDL-
cholesterol flux induced by thermogenic activation.
Discussion
Thermogenic brown and beige adipocytes are critical regulators
of whole-body energy metabolism and plasma lipoprotein
homeostasis9,52,53. While generally the metabolic activity of
thermogenic adipocytes is thought to act as a sink for excess
calories, in addition our study demonstrates that the activation of
thermogenic adipocytes is associated with increased HDL-
cholesterol flux from plasma into faeces. To our knowledge this
is the first study showing a physiologic condition, in which HDL
flux and HDL levels are disconnected. Second, this is the first
mechanistic report addressing the relationship of increased
metabolism by thermogenic adipocytes and HDL metabolism.
We show in genetic loss-of-function models that the increase in
HDL turnover was dependent on adipocyte LPL-dependent
lipolytic processing and selective HDL-cholesterol disposal in
the liver via SR-BI. While our study found substantial changes in
the HDL lipidome after stimulation of thermogenic adipocytes,
our data indicate that this is not functionally related to increased
cholesterol flux through the HDL compartment as observed in
the animals. Rather, we propose a mechanism where lipolysis-
driven transfer of TRL-derived surface remnants to HDL, as
proposed by Eisenberg et al. based on in vitro experiments54,55,
accelerates the metabolic flux of HDL-cholesterol to the liver.
Supporting this hypothesis, changes in PC species induced by
cold adaptation were similar in HDL and TRL. Interestingly, the
exchange of CE species between HDL and TRL particles was only
observed in E3L.CETP but not Apoa5 / mice, confirming that
CETP activity promotes the transfer of core lipids also in the
context of thermogenic adipocyte stimulation. In the future, it























































































Figure 4 | Cold exposure induces HDL lipidome remodelling in humans. Plasma lipoprotein profiles determined by FPLC in (a) 9 lean and (b) 10 obese
humans before and after 2 day-treatment with cold. Changes in (c) PC, (d) lyso-PC and (e) CE species in HDL from cold-treated individuals relative to their
baseline levels are represented as per cent weight changes of total lipid class. Calculated values are mean±s.e.m. (n¼9–10 per group). Post hoc correction
for multiple testing was performed using the Benjamini–Hochberg method for the number of lipids shown.*Po0.05, **Po0.01, versus mock (Student’s t-
test).
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exchanges between lipoprotein particles regarding lipid classes,
lipid species, directionality, enzymes and transfer proteins under
conditions of thermogenic activation. In this context, it will be
also important to investigate how our results in normo- and
hyperlipidemic mouse models here can be translated into humans
with different types of dyslipidemias. For instance, the effect of
thermogenic adipocytes on HDL is likely masked in
hypertriglyceridemic patients without functional LPL activity.
Thermogenic activation by cold exposure is accompanied by a
robust increase in food intake to maintain systemic energy
homeostasis. The resulting increased intake of cholesterol or
related sterols requires adaptive mechanisms to avoid a systemic
sterol overload. This is particularly important for BAT, which,
when active, takes up whole TRL lipoprotein particles including
cholesterol53,56. One mechanism counteracting cholesterol
accumulation in thermogenic adipocytes might involve direct
cholesterol efflux from adipocytes to HDL. Adipocyte ABCA1 has
been demonstrated to contribute to HDL maturation both
in vivo57 and in vitro58. In addition, genetic ablation of ABCG1
results in massive lipid accumulation in multiple tissues after
feeding a cholesterol-containing diet, offering the possibility that
ABCG1 may also play a critical role in WAT or BAT cholesterol
homeostasis59. Experiments using mice lacking ABCA1 or
ABCG1 specifically in thermogenic adipocytes will be needed to
show whether the high lipolytic activity of brown and beige
adipocytes not only increases intravascular HDL remodelling and
turnover as shown in this study, but also enhances cholesterol
efflux from brown and beige adipocytes60. On the other hand,
intestinal cholesterol handling could also be altered in the setting
of cold exposure, which might contribute to the stimulated RCT.
In line, decreased intestinal re-absorption of cholesterol was
previously found as the cause of reduced RCT in a mouse model
of restraint stress61.
We found that the characteristic changes in the HDL lipidome
were basically also observed in lean humans, but, interestingly,
not in obese probands. It remains to be proven, however, whether
the decrease of human brown fat activity that is observed with
ageing, obesity and insulin resistance2,5,62,63 is causally linked to a
general deterioration of plasma lipids homeostasis and increased
risk of cardiovascular disease (CVD)64. On the other hand, the
linkage of TG turnover and HDL-cholesterol flux under conditions
of increased energy expenditure exemplified here by the
stimulation of thermogenic adipocytes might also be causally
















































































































































































































































































Figure 5 | Thermogenic adipocytes promote reverse cholesterol transport without altering cholesterol efflux capacity of HDL. Serum and HDL were
prepared from wild-type C57BL/6J mice housed at thermoneutrality (mock), at 4 C (cold) or treated with CL for 7 days. Peritoneal macrophages were pre-
loaded with 3H-cholesterol and specific cholesterol efflux was induced (a) in the absence (control) or in the presence of 2% serum for the indicated time or
(b) in the absence (IM¼ incubation medium) or in the presence of 2% serum or 50mgml 1 HDL for 4 h at 37 C. Values are mean±s.e.m. of n¼ 3
independent experiments. *Po0.05, versus mock (Student’s t-test). For metabolic turnover studies, HDL from untreated (mock-HDL) or CL-treated (CL-
HDL) wild-type C57BL/6J mice were radiolabelled. After injection of 125I-protein shell- and 3H-cholesterol oleoyl ether core-radiolabelled HDL, (c) plasma
clearance and (d) liver uptake of 3H-cholesterol oleoyl ether were determined. Values are mean±s.e.m. (n¼ 7 per group). In vivo RCT assay in
thermoneutral (mock), CL-treated and cold-exposed (e–g) C57BL/6J and (h–j) E3L.CETP mice after the injection of peritoneal macrophages, ex vivo loaded
with LDL and 3H-cholesterol. Radioactivity was determined 48 h after macrophage injection (e,h) in plasma and (f,i) in liver as well as (g,j) 24 h and 48 h
after macrophage injection in faeces. Values are mean±s.e.m. (n¼ 8–10 per group).*Po0.05, **Po0.01, ***Po0.001, versus mock (Student’s t-test).
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cardiovascular risk65. Also, as cold adaptation involves a certain
contribution of shivering thermogenesis, it might explain why we
found that cold adaptation has more pronounced effects on HDL
metabolism than CL treatment alone, indicating a possible contri-
bution of muscle-mediated lipolysis during cold. Furthermore, as
we used Fabp4-Cre to delete LPL from adipocytes, it is possible
that other cell types like macrophages play an additional role in
the processing of TRL and HDL under cold conditions. In light
of recent studies demonstrating the therapeutic potential of
BAT activation in humans10,12,13, it is tempting to speculate
that stimulating thermogenic adipocyte activity may protect
from cardiovascular disease not only by decreasing remnant
lipoproteins levels9 but also by stimulating HDL-cholesterol flux
from atherogenic lesions to the liver for ultimate cholesterol
excretion.
Methods
Experimental animals and diets. All animal experiments were approved by the
Animal Welfare Officers of University Medical Center Hamburg-Eppendorf (UKE)
and Behörde für Gesundheit und Verbraucherschutz Hamburg as well as the
Institutional Ethical Committee on Animal Care and Experimentation of the
Leiden University Medical Center. Mice were bred in the animal facilities at 22 C
with a day and night cycle of 12 h. We used male age-matched (12–18 weeks):
C57BL/6J wild-type mice were received from Charles River Germany; Fabp4-Creþ
mice from Jackson Laboratories (Bar Harbor, ME; # 005069); Lpl-floxed mice from
Jackson Laboratories (Bar Harbor, ME; # 006503), Scarb1–/– from Jackson
Laboratories (Bar Harbor, ME; # 003379). These mice were obtained on a C57BL/6J
background and were bred at the UKE animal facilities. Breeder pairs of Apoa5–/–
mice were kindly provided by Dr Len Pennacchio (Lawrence Berkeley National
Laboratory) and backcrossed to the FVB background for more than 10 generations.
E3L female mice (line 2; generated at Leiden University Medical Center) crossbred
with mice expressing human CE transfer protein (received from Jackson
Laboratories, Bar Harbor, ME; # 003904) to generate E3L.CETP on C57BL/6J













































































































































































































































































































































































Figure 6 | Lipolysis by LPL and hepatic SR-BI increase cold-induced HDL turnover. 125I-protein shell- and 3H-cholesteryl oleoyl ether (CEt) core-
radiolabelled HDL were injected into (a–c) fasted and (d–f) re-fed C57BL/6J mice, which had been either cold-exposed for 7 days (cold) or kept under
thermoneutral conditions (warm). Double-labelled HDL were also injected into fasted mice cold-adapted for 7 days with (g–i) adipocyte-specific LPL
knockout (aLKO) and (j–l) Scarb1 / mice and wild-type (WT) controls. HDL-derived 3H-CEt clearance from plasma was analysed at indicated time
points by determining (a,d,g,j) total and (b,e,h,k) selective clearance. Values for selective clearance are presented as the ratio of 3H/125I radioactivity and
calculated for each time point indicated (an accelerated selective HDL-cholesterol clearance from plasma is indicated by a lower ratio of 3H/125I while
impaired plasma clearance leads to higher 3H/125I). (c,f,i,l) The organ uptake of HDL-3H-CEt was measured 5 h after injection of radiolabelled HDL. gWAT,
gonadal WAT; iWAT, inguinal WAT; iBAT, interscapular BAT. Values are mean±s.e.m. (n¼ 5-7 per group). *Po0.05, **Po0.01, ***Po0.001, versus control
(Student’s t-test).
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experiments, mice were randomized based on their body weights and were housed
in single cages and fed a standard chow diet (Lasvendi), unless indicated otherwise.
Cold exposure was performed by housing mice at 4 C for 1 week, whereas control
mice were housed at thermoneutrality. The b3-adrenergic agonist CL316,243
(Tocris, 0.2mgml 1 in 0.9 w/v % NaCl) was administered by subcutaneous
injection (1 mg per g body weight per day) for 7 days, mock-treated control mice
received 0.9 w/v % NaCl correspondingly.
If not stated otherwise, tissue and blood collections were performed after 4 h
fasting initiated between 8:00 and 9:00 am. Mice were anaesthetized with a lethal
dose (15ml g 1 mouse body weight) of a mix containing Ketamin (25mgml 1)/
Xylazin (0.2%) in 0.9% NaCl. Blood was withdrawn transcardially with syringes
containing 0.5M EDTA for plasma preparation and animals were perfused with
5ml ice-cold PBS containing 10Uml 1 heparin. Organs were harvested and
immediately conserved either in TRIzol reagent (Invitrogen), phosphate-buffered
3.7% formaldehyde or snap-frozen in liquid N2 and stored at  80 C for further
processing. For practical reasons, investigators were not blinded as to the group
allocation.
Plasma parameters. Plasma TG and cholesterol were measured using commercial
kits (Roche) that were adapted to 96-well microtiter plates. HDL-cholesterol levels
were measured after precipitating apoB-containing lipoproteins from plasma by
addition of 20% polyethylene glycol in 200mM glycine buffer with pH 10. For
lipoprotein profiling, 200ml of plasma was separated by FPLC using a Superose 6
10/300 GL column (GE Healthcare) with a flow rate of 0.5mlmin 1. 28 fractions
(volume of factions 0.5ml) were collected. In each fraction, TG as well as cho-
lesterol levels were determined. For further analysis, FPLC fractions 4-6 (TRLs) and
17-20 (HDL) were pooled (350 ml per well) and stored at  80 C immediately after
FPLC for further processing.
Lipid extraction and high-resolution lipidomics. FPLC fractions were spiked
with several internal standards (see list Supplementary Table 1; obtained from
Sigma-Aldrich or Avanti Polar Lipids) before lipid extraction by the method of
Bligh and Dyer67, respectively. The lipid extraction of FPLC fractions was
performed with 320 ml of the pooled FPLC fractions (TRL, HDL; see above). After
addition of 1,000 ml methanol, 50ml internal standard (diluted 1:10) and 700 ml
chloroform the tube is stirred for 30 s on a Vortex-shaker. 1,100 ml chloroform and
900ml MS-grade-water was added and the solution was again stirred for 30 s on a
Vortex-shaker. Samples were centrifuged at 4 C for 15min at 3,000 g. 1,600 ml of
the lower organic phase was transferred to a new glass tube and the solvent was
evaporated to dryness by vacuum centrifugation using a ZentriVac. The lipid
extracts were resuspended in 80 ml of eluent B and transferred to glass vials.
Lipidomic analyses were conducted on a Dionex3000 UPLC (Column: Kinetex
C18, 150 2.1mm; 1.7 mm (Phenomenex)) coupled to an ESI-UHR-Q-TOF mass
spectromereeter (maXis3G, Bruker Daltonik). Data w acquired using high-
resolution, full scan MS and collisional induced dissociation fragmentation. For
chromatography the following gradient with a flow rate of 300 ml min 1 was
performed: 0min 80% B, in 2min to 87% B, 6min isocratic, in 2min to 95% B, in
10min to 99% B, 1min isocratic, in 1min to 80% B, 3min isocratic. Eluent A
consisted of ultra-pure water enriched with 5mM NH4Ac, eluent B of MeOH/IPA,
4/6 (vol/vol) enriched with 5mM NH4Ac. Column temperature was maintained at
55 C. The mass spectrometer was operated in positive ionization mode: A capillary
voltage of 4.5 kV and an end plate offset voltage of  500V were applied. The inlet
LC flow was nebulized using nitrogen gas (2 bar), the dry temperature was kept at
190 C. Data were acquired over the mass range of 100–1,000Da for both MS and
MS/MS modes. Nitrogen was used for collisional induced dissociation with
collision energies between 14 and 35. Obtained spectra were externally calibrated
on ESI-L tuning mix (Agilent Technologies) running via syringe pump at
20ml h 1. Further internal calibration was performed for each sample by using the
lockmass hexakis (1H, 1H, 2H-perfluoroethoxy) phosphazene (Apollo Scientific
Limited). UPLC-MS data were processed using the manufacturer software
(DataAnalysis 4.0 and TargetAnalysis 1.3). Only peak areas of individual lipid
species that were within the range of external calibration curves were calculated by
comparing the individual peak areas with those of corresponding internal
standards for determining the final concentrations. Lipid species were identified by
means of standard substances, MS/MS-spectra (see list of fragment sizes in
Supplementary Table 2) and the LIPID MAPS database (http://www.lipidmaps.org/
tools/index.html). We detected 7-15 CEs, 7-15 LysoPCs and 18-30 PCs. However,
Figs 3 and 4 show the ten or five most consistently detected species for the depicted
lipid classes representing the highest common denominator of all analyses.
Human HDL. All participants signed an informed consent for the study protocol,
which was approved by the institutional review board of Maastricht University
Medical Center. Blood samples were obtained from nine male lean (BMI 20.8–
24.8 kgm 2) and 10 male obese (BMI 28.6–40.8 kgm 2) subjects after they stayed
for 36 h at a neutral temperature (22 C, control) and after 48 h exposure to mild
cold (16 C, cold) as described previously48. In brief, subjects stayed in a respiration
chamber for 84 h with standardized clothing. The first 36 h the chamber
temperature was set to 22 C (baseline); the following 48 h chamber temperature
was set to 16 C (mild cold exposure). The temperature of the mild cold situation
(16 C) has been validated earlier with similar clothing to be slightly above the
shivering threshold. Blood samples were taken in the fasted state under baseline
conditions and 48 h after mild cold exposure. EDTA-plasma was obtained by
centrifugation, frozen in liquid nitrogen and stored at  80 C until further
analysis. Individual HDL samples were isolated by FPLC using a Superose 6
column (GE Healthcare Life Sciences) from lean and obese subjects before and
after cold exposure. Lipid species were determined by UPLC-ESI-UHR-TOF as
described above.
Gene expression analysis. Total RNA was isolated from tissue samples using
NucleoSpin RNA II kit (Macherey & Nagel). Synthesis of complementary DNA
was performed using SuperScript III Reverse Transcriptase (Invitrogen). Quanti-
tative real-time PCR reactions for indicated genes were conducted on a 7900HT
sequence detection system (Applied Biosystems) using TaqManAssay-on-Demand
primer sets (Applied Biosystems, Ucp1: Mm00494069_m1, Ppargc1a:
Mm00447183_m1) supplied by Applied Biosystems and selected to recognize
RefSeq sequences and a maximum of Genbank ESTs. Gene of interest cycle
thresholds (Cts) were normalized to TATA-box binding protein (Tbp) house keeper
levels by the DDCt method and displayed as relative copies per Tbp or relative
expression normalized to experimental control groups.
Western blot. Frozen liver samples were prepared for SDS–PAGE using a
radioimmunoprecipitation assay buffer supplemented with protease inhibitors
(Roche). Protein samples (15 mg per lane) were separated on a 10% Bis-Tris (pH
6.6) polyacrylamide gel using NuPAGE MES SDS Running Buffer under reducing
conditions (Invitrogen). After the transfer to nitrocellulose membranes, blots were
blocked for 2 h in PanReac Blocking buffer (AppliChem) and incubated for 1 h at
room temperature with the primary antibody against SR-B1 (NB400-101; Novus
Biologicals) and against b-actin (A2228; Sigma). Membranes were incubated for
90min in secondary horseradish peroxidase conjugated antibodies (goat anti-
rabbit, Jackson Immunoresearch, 1:5,000). Detection of protein bands was per-
formed using a luminol/para-hydroxycoumarinic acid-based chemiluminescence
substrate.
HDL turnover assay. For HDL preparation, C57BL/6J WT mice were fasted 4 h
before blood withdrawal. After isolation of HDL (d¼ 1.063–1.21 gml 1) by
sequential ultracentrifugation68, purified HDL were double-labelled with
125I-tyramine cellobiose (125I-TC) in the apolipoprotein moiety and with
3H-Cholesteryl oleoyl ether (CEt) in the lipoprotein core35. Using human plasma
CETP, 3H-CEt was introduced into 125I-TC-HDL by exchange from donor
liposomal particles, which contained 3H-Cet. The final 125I-TC-/3H-Cet-HDL
particles were dialyzed against PBS (pH 7.4, 4 C) containing 1mM EDTA.
For analysis of plasma decay and organ uptake of radiolabelled HDL, mice were
fasted for 4 h before tracer injection. After injection of 125I-TC- / 3H-CEt-HDL
(30 mg HDL protein per mouse; ca. 39 kBq 125I-TC and 33 kBq 3H-CEt,
respectively) via the tail vein, blood samples were collected at given times after
injection: 10 and 30min; 1, 2 and 5 h. Plasma aliquots and tissues were directly
assayed for 125I radioactivity whereas 3H-radioactivity was analysed by scintillation
counting after lipid extraction using the method of Dole69.
In vivo reverse cholesterol transport assay. In vivo RCT was assayed by a
method developed by Dan Rader and colleagues49. For the preparation of
peritoneal macrophages, Ldlr–/– mice were injected with 2ml thioglycollate 4 days
before isolation by peritoneal lavage with warm DMEM. Cells were plated and after
4 h radiolabelled ex vivo with tracer 3H-cholesterol (100 kBq corresponding to
1.5 106 cells per mouse) and loaded with cholesterol by overnight incubation
with acetylated LDL (20 mgml 1). To avoid shear stress we used 0.55 25mm 24
G 10 0 Gr. 17 needles (Braun) for the intraperitoneal injection of 1 106
radiolabelled macrophages. During the 48 h experiment, mice were kept in special
cages that prevented the mice from tampering with the faeces. Faeces, tissue and
blood collections were performed 48 h after macrophage injection. 3H-radioactivity
of plasma, faeces and organs was measured as described above.
In vitro cholesterol efflux assay. Peritoneal macrophages and HDL from control,
CL-treated and cold-exposed were isolated as described above. Cells were incubated
overnight at 37 C with 3H-cholesterol (37 kBqml 1) and 20 mgml 1 LDL in
DMEM containing 0.1% BSA. Then, cells were washed using pre-warmed DMEM
and surface-bound LDL was removed using 100 U heparin diluted in DMEM. Cells
were incubated for additional 240min at 37 C in DMEMþ 0.1% BSA to allow
unspecific cholesterol efflux. Then, cells were washed using pre-warmed DMEM
and specific cholesterol efflux was induced in the absence or in the presence of 2%
serum or 50 mg/ml HDL for 60-240min at 37 C. Media were harvested and cells
were lysed in 0.1N NaOH, radioactivity was determined by scintillation counting
and 3H-cholesterol efflux was calculated in %.
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Histology. Anaesthetized mice were perfused with PBS containing 2% for-
maldehyde. Adipose tissues were embedded in paraffin. Haematoxylin and eosin
staining was performed using standard protocols as described70.
Statistics. Data are expressed as mean±s.e.m. Student’s t-test, one- or two-way
ANOVA were used for comparison between groups. The estimated variation
within each group of an experiment was similar. No statistical method was used to
predetermine sample size. For comparison of lipidomic data, post hoc correction
for multiple testing was performed using the Benjamini–Hochberg method for the
number of lipids shown in the respective figures. Univariate regression analyses
were performed to test for significant correlations. Square root of the lesion area
was taken to linearize the relationship with the plasma HDL-cholesterol exposure
in E3L.CETP mice. GraphPad Prism 5.0 or SPSS 20.0 were used for statistical
calculations with statistically significant differences denoted as *Po0.05.
Data availability. The datasets generated during and/or analysed during the
current study are available from the corresponding authors upon reasonable request.
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